DE69229393D1 - Verfahren zur reinigung von hmg-coa reductase-inhibitoren - Google Patents

Verfahren zur reinigung von hmg-coa reductase-inhibitoren

Info

Publication number
DE69229393D1
DE69229393D1 DE69229393T DE69229393T DE69229393D1 DE 69229393 D1 DE69229393 D1 DE 69229393D1 DE 69229393 T DE69229393 T DE 69229393T DE 69229393 T DE69229393 T DE 69229393T DE 69229393 D1 DE69229393 D1 DE 69229393D1
Authority
DE
Germany
Prior art keywords
coa reductase
reductase inhibitors
hmg
purifying
purifying hmg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229393T
Other languages
English (en)
Inventor
Peter Haytko
Arthur Wildman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24683910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69229393(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69229393D1 publication Critical patent/DE69229393D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/322—Normal bonded phase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69229393T 1991-03-13 1992-03-09 Verfahren zur reinigung von hmg-coa reductase-inhibitoren Expired - Lifetime DE69229393D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/668,831 US5202029A (en) 1991-03-13 1991-03-13 Process for purification of hmg-coa reductase inhibitors
PCT/US1992/001864 WO1992016276A1 (en) 1991-03-13 1992-03-09 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS

Publications (1)

Publication Number Publication Date
DE69229393D1 true DE69229393D1 (de) 1999-07-15

Family

ID=24683910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229393T Expired - Lifetime DE69229393D1 (de) 1991-03-13 1992-03-09 Verfahren zur reinigung von hmg-coa reductase-inhibitoren

Country Status (9)

Country Link
US (1) US5202029A (de)
EP (1) EP0578723B1 (de)
JP (1) JPH06506210A (de)
AT (1) ATE180986T1 (de)
CA (1) CA2104232A1 (de)
DE (1) DE69229393D1 (de)
ES (1) ES2132121T3 (de)
GR (1) GR3030446T3 (de)
WO (1) WO1992016276A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308479A (en) * 1989-05-26 1994-05-03 Isamu Iwai Sewage disposal apparatus employing circulating filter media
DE4414537A1 (de) * 1994-04-26 1995-11-02 Klinge Co Chem Pharm Fab Kombinationspräparate mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem HMG-CoA-Reduktase-Hemmer
SI9800046A (sl) 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
AU8030900A (en) 1999-10-27 2001-05-08 Merck & Co., Inc. Lactonization process
EP1265604B1 (de) 1999-11-30 2006-10-18 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Verfahren zur rückgewinnung von statinverbindungen aus einer fermentationsbrühe
IL150187A0 (en) * 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
KR20030013373A (ko) 2000-02-24 2003-02-14 비오갈 기오기스제르갸르 알티. 발효 브로스의 정제 방법
DE01913139T1 (de) * 2000-03-03 2005-03-31 Plus Chemical S.A. Ein verfahren zur reinigung von lovastatin und simvastatin mit verringertem gehalt an dimeren verunreinigungen
JP4945876B2 (ja) * 2000-04-05 2012-06-06 東レ株式会社 ハイモビリティーグループタンパクの吸着材および体液浄化カラム
US6936731B2 (en) * 2000-10-05 2005-08-30 TEVA Gyógyszergyár Részvénytársaság Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
IL155194A0 (en) * 2000-10-05 2003-11-23 Biogal Pharmaceutical Co Ltd Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
US20050215636A1 (en) * 2000-10-05 2005-09-29 Vilmos Keri Pravastatin sodium substantially free of pravastatin lactone and EPI-pravastatin, and compositions containing same
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
US7368468B2 (en) * 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
EP1719759A3 (de) * 2003-06-18 2007-03-21 Teva Pharmaceutical Industries, Inc. Fluvastatin-Natrium-Kristallmodifikation LXXIII, Verfahren zu deren Herstellung, Zusammensetzungen, die diese enthalten und Verfahren zu deren Anwendung
CA2546701C (en) * 2003-11-24 2010-07-27 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
TWI319707B (en) 2003-11-24 2010-01-21 Method of purifying pravastatin
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
ES2239533B1 (es) * 2004-03-01 2006-12-16 Ercros Industrial, S.A. Procedimiento para la obtencion de compactina.
WO2006035295A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Process for the purification of lovastatin
WO2006091770A2 (en) 2005-02-22 2006-08-31 Teva Pharmaceutical Industries Ltd. Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
WO2009078033A2 (en) * 2007-12-18 2009-06-25 Themis Medicare Limited Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
CN102625705B (zh) * 2009-04-08 2015-05-06 南洋理工学院 包含他汀类药物的植物提取物及其制备技术和用途
CN102043030A (zh) * 2009-10-22 2011-05-04 北京万全阳光医学技术有限公司 一种用高效液相色谱法测定烟酸辛伐他汀缓释片有关物质的方法
AU2011296528B2 (en) * 2010-07-07 2015-08-06 Ironstone Separations, Inc. Chromatography methods
EP2597092A1 (de) 2011-11-24 2013-05-29 Sterling Biotech Limited Verfahren zum Reinigen von Lovastatin
CN112657231B (zh) * 2020-12-24 2022-06-10 西安蓝晓科技新材料股份有限公司 一种三七总皂苷的提纯工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS58140024A (ja) * 1982-02-15 1983-08-19 Eisai Co Ltd セクレチンの精製方法
US4833258A (en) * 1987-02-17 1989-05-23 Merck & Co., Inc. Intermediates useful in the preparation of HMG-COA reductase inhibitors
US4719229A (en) * 1987-05-13 1988-01-12 Merck & Co., Inc. Antihypercholesterolemic agents
US4778600A (en) * 1987-06-17 1988-10-18 Dow Corning Corporation Liquid chromatography dual zone packing materials
US4997755A (en) * 1988-04-15 1991-03-05 Merck & Co., Inc. HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455)
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5102911A (en) * 1989-06-09 1992-04-07 Merck & Co, Inc. 4-Substituted HMG-CoA reductase inhibitors
US4965200A (en) * 1989-06-23 1990-10-23 Merck & Co., Inc. Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US5089523A (en) * 1990-05-11 1992-02-18 E. R. Squibb & Sons, Inc. Fluorinated derivatives of mevinic acids

Also Published As

Publication number Publication date
ATE180986T1 (de) 1999-06-15
EP0578723A4 (en) 1994-06-22
ES2132121T3 (es) 1999-08-16
EP0578723A1 (de) 1994-01-19
JPH06506210A (ja) 1994-07-14
WO1992016276A1 (en) 1992-10-01
EP0578723B1 (de) 1999-06-09
GR3030446T3 (en) 1999-09-30
CA2104232A1 (en) 1992-09-14
US5202029A (en) 1993-04-13

Similar Documents

Publication Publication Date Title
ATE180986T1 (de) Verfahren zur reinigung von hmg-coa reductase- inhibitoren
DE69529936T2 (de) Verfahren zur Quantifizierung von spezifischen Verbindungen
DE69818304D1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69406059D1 (de) Verfahren zur Gasphasenpolymerisation von Olefin
BR9506535A (pt) Inibidores de metaloproteinases
DE69310324D1 (de) Verfahren zur Entschwefelung von Kohlenwasserstoffen
DE69508733D1 (de) Verfahren zur Carboxylierung eines Alkohols
DE69400257D1 (de) Verfahren zur Reinigung von Pentafluorethan
DE69412559D1 (de) Verfahren zur Vergasung von organischen Materien
DE59603541D1 (de) Verfahren zur Reinigung von Bisphenol-A
DE69202962D1 (de) Verfahren zur Glycidylierung von Alkoholen.
FI962086A0 (fi) Faasierotuslaite
DE69633579D1 (de) Verfahren zur Rückgewinnung von Quecksilber
DE69314365D1 (de) Verfahren zur Monohydroxylierung von Phenolverbindungen
DE69433634D1 (de) Verfahren zur Umsetzung von Kohlenwasserstoffen
EA199900221A1 (ru) Синтез бисиндолилмалеимидов
DE69415837D1 (de) Verfahren zur Verminderung des freien Aldehydgehaltes von N-Alkylolamidmonomeren
DE69411333D1 (de) Verfahren zur Rückgewinnung von verbrauchten Metallätzlösungen
DE69403489D1 (de) Gasphasenverfahren zur epoxidation von nicht-allylischen olefinen
ATE200079T1 (de) Verfahren zur herstellung von hiv-proteasehemmern
DE69309517D1 (de) Verfahren zur Ammoxydation von gesättigten Kohlenwasserstoffen
DE69212731D1 (de) Verfahren zur elektro-osmotischen Entwässerung von Schlamm
DE59303043D1 (de) Verfahren zur entsorgung des überschussschlammes
DE69406205D1 (de) Verfahren zur Isomerisierung von Cis-Alkenylverbindungen
DE69501535D1 (de) Verfahren zur Reinigung von Difluormethan

Legal Events

Date Code Title Description
8332 No legal effect for de